{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:35:44Z","timestamp":1788536144478,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09628-7","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T03:02:24Z","timestamp":1683946944000},"page":"6726-6735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9325-2762","authenticated-orcid":false,"given":"Adarsh","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ensar","family":"Yekeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Reis","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"States","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"9628_CR1","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1542\/peds.2007-2964","volume":"121","author":"J Li","year":"2008","unstructured":"Li J, Thompson TD, Miller JW et al (2008) Cancer incidence among children and adolescents in the United States, 2001\u20132003. Pediatrics 121:e1470\u2013e1477. https:\/\/doi.org\/10.1542\/peds.2007-2964","journal-title":"Pediatrics"},{"key":"9628_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jjco\/hyx176","volume":"48","author":"A Nakagawara","year":"2018","unstructured":"Nakagawara A, Li Y, Izumi H et al (2018) Neuroblastoma. Jpn J Clin Oncol 48:214\u2013241. https:\/\/doi.org\/10.1093\/jjco\/hyx176","journal-title":"Jpn J Clin Oncol"},{"key":"9628_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00441-017-2761-2","volume":"372","author":"GM Brodeur","year":"2018","unstructured":"Brodeur GM (2018) Spontaneous regression of neuroblastoma. Cell Tissue Res 372:277\u2013286. https:\/\/doi.org\/10.1007\/s00441-017-2761-2","journal-title":"Cell Tissue Res"},{"key":"9628_CR4","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1200\/JCO.2005.05.571","volume":"23","author":"WB London","year":"2005","unstructured":"London WB, Castleberry RP, Matthay KK et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children\u2019s Oncology Group. J Clin Oncol 23:6459\u20136465. https:\/\/doi.org\/10.1200\/JCO.2005.05.571","journal-title":"J Clin Oncol"},{"key":"9628_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson ADJ, London WB et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27:289\u2013297. https:\/\/doi.org\/10.1200\/JCO.2008.16.6785","journal-title":"J Clin Oncol"},{"key":"9628_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27:298\u2013303. https:\/\/doi.org\/10.1200\/JCO.2008.16.6876","journal-title":"J Clin Oncol"},{"issue":"4","key":"9628_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/genes8040113","volume":"8","author":"MV Ruiz-P\u00e9rez","year":"2017","unstructured":"Ruiz-P\u00e9rez MV, Henley AB, Arsenian-Henriksson M (2017) The MYCN protein in health and disease. Genes 8(4):113. https:\/\/doi.org\/10.3390\/genes8040113","journal-title":"Genes"},{"key":"9628_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00381-022-05534-3","volume":"38","author":"E Tan","year":"2022","unstructured":"Tan E, Merchant K, Kn BP et al (2022) CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma. Childs Nerv Syst 38:1487\u20131495. https:\/\/doi.org\/10.1007\/s00381-022-05534-3","journal-title":"Childs Nerv Syst"},{"key":"9628_CR9","doi-asserted-by":"publisher","unstructured":"Chen X, Wang H, Huang K et al (2021) CT-based radiomics signature with machine learning predicts MYCN amplification in pediatric abdominal neuroblastoma. Front Oncol 11:687884. https:\/\/doi.org\/10.3389\/fonc.2021.687884","DOI":"10.3389\/fonc.2021.687884"},{"key":"9628_CR10","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1007\/s00330-020-07246-1","volume":"31","author":"H Wu","year":"2021","unstructured":"Wu H, Wu C, Zheng H et al (2021) Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification. Eur Radiol 31:3080\u20133089. https:\/\/doi.org\/10.1007\/s00330-020-07246-1","journal-title":"Eur Radiol"},{"key":"9628_CR11","doi-asserted-by":"publisher","unstructured":"Di Giannatale A, Di Paolo PL, Curione D et al (2021) Radiogenomics prediction for MYCN amplification in neuroblastoma: a hypothesis generating study. Pediatr Blood Cancer 68:e29110. https:\/\/doi.org\/10.1002\/pbc.29110","DOI":"10.1002\/pbc.29110"},{"key":"9628_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/sj.bjc.6605014","volume":"100","author":"PF Ambros","year":"2009","unstructured":"Ambros PF, Ambros IM, Brodeur GM et al (2009) International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 100:1471\u20131482. https:\/\/doi.org\/10.1038\/sj.bjc.6605014","journal-title":"Br J Cancer"},{"key":"9628_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1158\/1078-0432.CCR-08-1648","volume":"15","author":"J Theissen","year":"2009","unstructured":"Theissen J, Boensch M, Spitz R et al (2009) Heterogeneity of the MYCN oncogene in neuroblastoma. Clin Cancer Res 15:2085\u20132090. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1648","journal-title":"Clin Cancer Res"},{"key":"9628_CR14","doi-asserted-by":"publisher","unstructured":"Qian L, Yang S, Zhang S et al (2022) Prediction of MYCN amplification, 1p and 11q aberrations in pediatric neuroblastoma via pre-therapy 18F-FDG PET\/CT radiomics. Front Med (Lausanne) 9:840777. https:\/\/doi.org\/10.3389\/fmed.2022.840777","DOI":"10.3389\/fmed.2022.840777"},{"issue":"2","key":"9628_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/diagnostics12020262","volume":"12","author":"L Feng","year":"2022","unstructured":"Feng L, Qian L, Yang S et al (2022) Prediction for mitosis-karyorrhexis index status of pediatric neuroblastoma via machine learning based 18F-FDG PET\/CT radiomics. Diagnostics 12(2):262. https:\/\/doi.org\/10.3390\/diagnostics12020262","journal-title":"Diagnostics"},{"key":"9628_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12880-022-00828-z","volume":"22","author":"L Feng","year":"2022","unstructured":"Feng L, Qian L, Yang S et al (2022) Clinical parameters combined with radiomics features of PET\/CT can predict recurrence in patients with high-risk pediatric neuroblastoma. BMC Med Imaging 22:102. https:\/\/doi.org\/10.1186\/s12880-022-00828-z","journal-title":"BMC Med Imaging"},{"key":"9628_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10278-022-00607-w","volume":"35","author":"G Liu","year":"2022","unstructured":"Liu G, Poon M, Zapala MA et al (2022) Incorporating radiomics into machine learning models to predict outcomes of neuroblastoma. J Digit Imaging 35:605\u2013612. https:\/\/doi.org\/10.1007\/s10278-022-00607-w","journal-title":"J Digit Imaging"},{"key":"9628_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28323","author":"K Sun","year":"2022","unstructured":"Sun K, Zhu H, Chai W, Yan F (2022) TP53 mutation estimation based on MRI radiomics analysis for breast cancer. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.28323","journal-title":"J Magn Reson Imaging"},{"key":"9628_CR19","doi-asserted-by":"publisher","unstructured":"Liu Y-F, Shu X, Qiao X-F et al (2022) Radiomics-based machine learning models for predicting P504s\/P63 immunohistochemical expression: a noninvasive diagnostic tool for prostate cancer. Front Oncol 12:911426. https:\/\/doi.org\/10.3389\/fonc.2022.911426","DOI":"10.3389\/fonc.2022.911426"},{"key":"9628_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab294","author":"A-K Mei\u00dfner","year":"2021","unstructured":"Mei\u00dfner A-K, Gutsche R, Galldiks N et al (2021) Radiomics for the non-invasive prediction of the BRAF mutation status in patients with melanoma brain metastases. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab294","journal-title":"Neuro Oncol"},{"key":"9628_CR21","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1038\/s41598-021-83593-3","volume":"11","author":"J Lee","year":"2021","unstructured":"Lee J, Steinmann A, Ding Y et al (2021) Radiomics feature robustness as measured using an MRI phantom. Sci Rep 11:3973. https:\/\/doi.org\/10.1038\/s41598-021-83593-3","journal-title":"Sci Rep"},{"key":"9628_CR22","doi-asserted-by":"publisher","first-page":"14248","DOI":"10.1038\/s41598-021-93756-x","volume":"11","author":"S Bernatz","year":"2021","unstructured":"Bernatz S, Zhdanovich Y, Ackermann J et al (2021) Impact of rescanning and repositioning on radiomic features employing a multi-object phantom in magnetic resonance imaging. Sci Rep 11:14248. https:\/\/doi.org\/10.1038\/s41598-021-93756-x","journal-title":"Sci Rep"},{"key":"9628_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.phro.2022.05.006","volume":"22","author":"N Saltybaeva","year":"2022","unstructured":"Saltybaeva N, Tanadini-Lang S, Vuong D et al (2022) Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: multi-center study. Phys Imaging Radiat Oncol 22:131\u2013136. https:\/\/doi.org\/10.1016\/j.phro.2022.05.006","journal-title":"Phys Imaging Radiat Oncol"},{"key":"9628_CR24","doi-asserted-by":"publisher","first-page":"15496","DOI":"10.1038\/s41598-020-72535-0","volume":"10","author":"A Cromb\u00e9","year":"2020","unstructured":"Cromb\u00e9 A, Kind M, Fadli D et al (2020) Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients. Sci Rep 10:15496. https:\/\/doi.org\/10.1038\/s41598-020-72535-0","journal-title":"Sci Rep"},{"key":"9628_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1109\/42.836373","volume":"19","author":"LG Ny\u00fal","year":"2000","unstructured":"Ny\u00fal LG, Udupa JK, Zhang X (2000) New variants of a method of MRI scale standardization. IEEE Trans Med Imaging 19:143\u2013150. https:\/\/doi.org\/10.1109\/42.836373","journal-title":"IEEE Trans Med Imaging"},{"key":"9628_CR26","doi-asserted-by":"publisher","unstructured":"Davatzikos C, Rathore S, Bakas S et al (2018) Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome. J Med Imaging (Bellingham) 5:011018. https:\/\/doi.org\/10.1117\/1.JMI.5.1.011018","DOI":"10.1117\/1.JMI.5.1.011018"},{"key":"9628_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/978-3-030-46643-5_38","volume":"11993","author":"S Pati","year":"2020","unstructured":"Pati S, Singh A, Rathore S et al (2020) The cancer imaging phenomics toolkit (captk): technical overview. Brainlesion 11993:380\u2013394. https:\/\/doi.org\/10.1007\/978-3-030-46643-5_38","journal-title":"Brainlesion"},{"key":"9628_CR28","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.3174\/ajnr.A3685","volume":"34","author":"S Diciotti","year":"2013","unstructured":"Diciotti S, Ciulli S, Mascalchi M et al (2013) The \u201cpeeking\u201d effect in supervised feature selection on diffusion tensor imaging data. AJNR Am J Neuroradiol 34:E107\u2013E107. https:\/\/doi.org\/10.3174\/ajnr.A3685","journal-title":"AJNR Am J Neuroradiol"},{"key":"9628_CR29","unstructured":"An Introduction to \u2018glmnet\u2019 \u2022 glmnet. https:\/\/glmnet.stanford.edu\/articles\/glmnet.html. Accessed 6 Dec 2022"},{"key":"9628_CR30","doi-asserted-by":"publisher","first-page":"8453","DOI":"10.1007\/s00330-022-08750-2","volume":"32","author":"A Ghosh","year":"2022","unstructured":"Ghosh A, Yekeler E, Dalal D et al (2022) Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results. Eur Radiol 32:8453\u20138462. https:\/\/doi.org\/10.1007\/s00330-022-08750-2","journal-title":"Eur Radiol"},{"key":"9628_CR31","doi-asserted-by":"publisher","unstructured":"Huang M, Weiss WA (2013) Neuroblastoma and MYCN. Cold Spring Harb Perspect Med 3:a014415. https:\/\/doi.org\/10.1101\/cshperspect.a014415","DOI":"10.1101\/cshperspect.a014415"},{"key":"9628_CR32","doi-asserted-by":"publisher","unstructured":"Lee JW, Son MH, Cho HW et al (2018) Clinical significance of MYCN amplification in patients with high-risk neuroblastoma. Pediatr Blood Cancer 65:e27257. https:\/\/doi.org\/10.1002\/pbc.27257","DOI":"10.1002\/pbc.27257"},{"key":"9628_CR33","doi-asserted-by":"publisher","unstructured":"Brisse HJ, Blanc T, Schleiermacher G et al (2017) Radiogenomics of neuroblastomas: relationships between imaging phenotypes, tumor genomic profile and survival. PLoS ONE 12:e0185190. https:\/\/doi.org\/10.1371\/journal.pone.0185190","DOI":"10.1371\/journal.pone.0185190"},{"key":"9628_CR34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1148\/rg.2021210037","volume":"41","author":"JD Shur","year":"2021","unstructured":"Shur JD, Doran SJ, Kumar S et al (2021) Radiomics in oncology: a practical guide. Radiographics 41:1717\u20131732. https:\/\/doi.org\/10.1148\/rg.2021210037","journal-title":"Radiographics"},{"key":"9628_CR35","unstructured":"Ro\u017eanec J, Po\u0161tuvan T, Fortuna B, Mladeni\u0107 D (2021) Tackling class imbalance in radiomics: the COVID-19 use case. In Ljubljana \u201921: Slovenian KDD Conference on Data Mining and Data Warehouses, October, 2021, Ljubljana, Slovenia. ACM, New York, NY, USA, p 4. https:\/\/ailab.ijs.si\/dunja\/SiKDD2021\/Papers\/Ro%C5%BEanecetal.pdf"},{"key":"9628_CR36","doi-asserted-by":"publisher","unstructured":"Vabalas A, Gowen E, Poliakoff E, Casson AJ (2019) Machine learning algorithm validation with a limited sample size. PLoS ONE 14:e0224365. https:\/\/doi.org\/10.1371\/journal.pone.0224365","DOI":"10.1371\/journal.pone.0224365"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09628-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:12:45Z","timestamp":1695197565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["9628"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09628-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Dr Lisa States.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A part of the data (<i>n<\/i>\u2009=\u200977) has been reported in the manuscript: Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN amplification in neuroblastomas: preliminary results","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 diagnostic\u2022 performed at one institution, but data obtained retrospectively from multiple sites","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}